ASC-102

N/A

Report date: 2026/04/17 10:36:30

Base Information

Drug NameASC-102

Drug Alias NameExtracellular superoxide dismutase - America Stem CellFucosyltransferase - TargazymeASC-201ASC-102TZ-102

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Tumor Infiltrating Lymphocytes

Mechanisms of ActionFucosyltransferase replacements

TargetsNot applicable

Therapy Area/IndicationsStrokeMultiple SclerosisHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesTargazyme Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTargazyme Inc

Active IndicationsN/A

Inactive IndicationsStrokeMultiple SclerosisHematologic Neoplasms

Other Information

ATC CodeN/A